HHealthcare Read More These 4 charts show the scale of Novo Nordisk’s woesFebruary 25, 2026 Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…
EEconomy Read More Unstable tariff situation and new AI disruption spark market sell-offFebruary 24, 2026 Futures-options traders work on the floor at the New York Stock Exchange’s NYSE American (AMEX) in New York…
HHealthcare Read More Eli Lilly launches Zepbound obesity drug pen with one month of dosesFebruary 23, 2026 An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March…
CCelebrities Read More Stocks making the biggest moves midday: KKR, BX, CRWD, IPFebruary 23, 2026 Check out the companies making the biggest moves midday: Financials — The financials sector of the S &…
HHealthcare Read More Eli Lilly CEO David Ricks talks Medicare coverage of obesity pillsJanuary 31, 2026 Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major…
HHealthcare Read More Eli Lilly plans $3.5 billion Pennsylvania plant for obesity drugsJanuary 30, 2026 Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik…
HHealthcare Read More 15 drugs added to Medicare price negotiationsJanuary 28, 2026 Boxes of the drug trulicity, made by Eli Lilly and Company, sit on a counter at a pharmacy…
HHealthcare Read More Another alliance of health care and AI signals why pharma stocks could be backJanuary 21, 2026 Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the…
HHealthcare Read More Novo Nordisk shares rise after Wegovy obesity pill launchJanuary 16, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan.…
MMedication Read More Novo Nordisk faces ‘must-win’ battle over U.S. Wegovy, Ozempic in 2026January 1, 2026 Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. (Photo by: Michael…
HHealthcare Read More Johnson & Johnson halts mid-stage trial of experimental eczema drugDecember 26, 2025 Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg |…
HHealthcare Read More Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on saleDecember 25, 2025 Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill…